Microbiology Testing/Clinical Microbiology Market Worth 4.95 Billion USD by 2023

Wednesday, June 27, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, June 27, 2018 /PRNewswire/ --

According to a new market research report "Microbiology Testing/Clinical Microbiology Market

 by Application (Pharma, Clinical, Manufacturing, Environment), Disease (Respiratory Disease, STD, UTI), Product (Instrument, Analyzer, Reagent), End User (Hospital, Diagnolab, Academia) - Global Forecast to 2023", published
by MarketsandMarkets™, the global market is expected to reach USD 4.95 billion by 2023 from USD 3.63 billion in 2018, at a CAGR of 6.4%.

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Browse 125 market data Tables and 50 Figures spread through 222 Pages and in-depth TOC on "Microbiology Testing/Clinical Microbiology Market"

https://www.marketsandmarkets.com/Market-Reports/microbiology-testing-market-219135367.html

Early buyers will receive 10% customization on this report 

The major factors driving the growth of the Clinical Microbiology Market include technological advancements in the field of infectious disease diagnostics, rising incidence and prevalence of infectious diseases and growing outbreak of epidemics, and the increased funding and public-private investments for the development of novel products for infectious disease diagnosis.

Pharmaceutical applications are expected to dominate the Microbiology Testing Market in 2018 

The Microbiology Testing Market is segmented on the basis of applications into pharmaceutical, clinical, food testing, energy, chemical and material manufacturing, and environmental applications. The pharmaceutical applications segment is expected to dominate the overall microbial testing market in 2018 due to the presence of well-established and globally accepted regulations that govern the evaluation of microbial contamination during pharmaceutical manufacturing and raw material sourcing processes.

Laboratory instruments are projected to hold the largest share of the clinical microbiology instruments market in 2018 

The Clinical Microbiology Market is segmented on the basis of products into instruments (laboratory instruments and microbiology analyzers) and reagents (pathogen-specific kits and general reagents). The laboratory instruments products segment is expected to command the largest share of the global clinical microbiology instruments market in 2018 due to factors such as continuous technological advancements in the field of microbiology testing instruments and the focus on laboratory automation (coupled with the integration of robotics with conventional microbiology instruments).

Respiratory diseases are expected to be the largest diseases area in Clinical Microbiology Market in 2018 

On the basis of disease area, the Clinical Microbiology Market is segmented into respiratory diseases, bloodstream infections (BSIs), gastrointestinal (GI) diseases, sexually transmitted diseases (STDs), urinary tract infections (UTIs), periodontal diseases, and other diseases (including cardiovascular disease, central nervous system infections, connective tissue & joint diseases, and skin diseases). The respiratory disease segment is estimated to account for largest share of the global Clinical Microbiology Market owing to the large patient population suffering from respiratory diseases, rising prevalence of target respiratory diseases (including TB, asthma, COPD, and bronchitis) across developing countries, and increasing number of epidemic outbreaks of respiratory infections.

Ask for PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=219135367

North America is expected to dominate the Clinical Microbiology Market in 2018 

Geographically, the market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, and the Rest of Europe), Asia Pacific (Japan, China, India, and the Rest of APAC), and the Rest of the World (Latin America, and the Middle East and Africa). North America is expected to account for the largest share of the global Clinical Microbiology Market in 2018 due to easy accessibility and high adoption of advanced diagnostic techniques, technological advancements in microbial testing techniques, rising geriatric population, and growing public-private funding to support microbiology-based research in the region.

The major players operating in the Microbiology Testing/Clinical Microbiology Market include bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche AG (Switzerland), Bruker Corporation (US), Hologic, Inc. (US), QIAGEN N.V. (The Netherlands), Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Shimadzu Corporation (Japan), 3M Company (US), and Neogen Corporation (US), among others.

Know more about the Microbiology Testing/Clinical Microbiology Market: 

https://www.marketsandmarkets.com/Market-Reports/microbiology-testing-market-219135367.html

About MarketsandMarkets™  

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact: Mr. Salgarkar MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com

Visit Our Blog: http://www.marketsandmarketsblog.com/market-reports/healthcare/medical-devices Connect with us on LinkedIn: http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store